- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 05.12.25 | XFRA NEW INSTRUMENTS AVAILABLE ON 05.12.2025 | 531 | Xetra Newsboard | The following instruments on XETRA do have their first trading 05.12.2025 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 05.12.2025
Aktien
1 US1409351079 CapsoVision Inc.
2... ► Artikel lesen | |
| 03.12.25 | Interventional Systems, Shoulder Innovations partner on shoulder-specific micro robotics | 1 | MassDevice | ||
| 03.12.25 | SHOULDER INNOVATIONS, INC. - 8-K, Current Report | - | SEC Filings | ||
| 12.11.25 | SHOULDER INNOVATIONS, INC. - 10-Q, Quarterly Report | - | SEC Filings | ||
| 12.11.25 | Why Shoulder Innovations Stock Is Skyrocketing Today | 1 | The Motley Fool | ||
| 12.11.25 | SHOULDER INNOVATIONS, INC. - 8-K, Current Report | - | SEC Filings | ||
| SHOULDER INNOVATIONS Aktie jetzt für 0€ handeln | |||||
| 12.11.25 | Morning Market Movers: Graphjet Technology, Shoulder Innovations, BILL Holdings, Black Rock Coffee Bar See Big Swings | 740 | AFX News | BEIJING (dpa-AFX) - At 7:15 a.m. ET on Wednesday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| 12.11.25 | Jefferies raises Shoulder Innovations stock price target to $20 on strong Q3 | 1 | Investing.com | ||
| 12.11.25 | Shoulder Innovations (SI) Stock Rose 21% After-Hours: Here's Why | 2 | Benzinga.com | ||
| 11.11.25 | Shoulder Innovations, Inc. GAAP EPS of -$0.64 misses by $0.26, revenue of $11.76M beats by $1.89M | 2 | Seeking Alpha | ||
| 11.11.25 | Shoulder Innovations Reports Third Quarter 2025 Financial Results and Increases Full-Year Revenue Guidance | 167 | PR Newswire | GRAND RAPIDS, Mich., Nov. 11, 2025 /PRNewswire/ -- Shoulder Innovations, Inc. (Shoulder Innovations, or the company) (NYSE: SI), a commercial-stage medical technology... ► Artikel lesen | |
| 10.11.25 | Shoulder Innovations, Inc. Q3 2025 Earnings Preview | 1 | Seeking Alpha | ||
| 22.09.25 | Shoulder Innovations launches new humeral stem implant nationwide | 1 | Investing.com | ||
| 22.09.25 | Shoulder Innovations startet landesweite Markteinführung für neues Humerusschaft-Implantat | 1 | Investing.com Deutsch | ||
| 09.09.25 | SHOULDER INNOVATIONS, INC. - 10-Q, Quarterly Report | 3 | SEC Filings | ||
| 09.09.25 | SHOULDER INNOVATIONS, INC. - 8-K, Current Report | 1 | SEC Filings | ||
| 09.09.25 | Shoulder Innovations Reports Second Quarter 2025 Financial Results | 184 | PR Newswire | Company to Participate in a Fireside Chat at the Morgan Stanley 23rd Annual Global Healthcare Conference Today at 8:30 a.m. ET
GRAND RAPIDS, Mich., Sept. 9,... ► Artikel lesen | |
| 26.08.25 | Goldmänner sehen über 33 Prozent Kurspotenzial bei dem jungem Medizintechnik-Wert Shoulder Innovations | 767 | ARIVA.de | Goldman Sachs sieht bei Shoulder Innovations ein Kurspotenzial von über 33 Prozent. Der frisch gelistete Spezialist für Schulterimplantate könnte dank eines wachsenden Marktes, neuer Produkte und IPO-Erlösen... ► Artikel lesen | |
| 25.08.25 | Morgan Stanley startet Coverage für Shoulder Innovations mit "Overweight" | 1 | Investing.com Deutsch | ||
| 25.08.25 | Shoulder Innovations stock initiated with Overweight rating at Morgan Stanley | 6 | Investing.com |
1 2 Weiter >>
36 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SIEMENS HEALTHINEERS | 46,100 | 0,00 % | DEUTSCHE BANK RESEARCH stuft Siemens Healthineers auf 'Hold' | FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat die Einstufung für Siemens Healthineers auf "Hold" mit einem Kursziel von 46 Euro belassen. Er rechne damit, dass der Start in das neue Geschäftsjahr... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 21,300 | +1,33 % | Where Alignment Healthcare Stands With Analysts | ||
| FRESENIUS MEDICAL CARE | 40,220 | 0,00 % | Abend-Update: Fresenius Medical Care sorgt für Spannung - kommt bald die Entscheidung? | ||
| FRESENIUS | 48,440 | 0,00 % | Amneal Pharma, MAbxience: FDA Approves Denosumab Biosimilars Referencing Amgen's Prolia And XGEVA | THOUSAND OAKS (dpa-AFX) - Amneal Pharmaceuticals, Inc. (AMRX) announced late Monday that the U.S. Food and Drug Administration has approved the Biologics Licensing Applications or BLAs for Boncresa... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 42,340 | 0,00 % | Abend-Update: Carl Zeiss Meditec-Aktie auf Höhenflug - Anleger feiern starkes Comeback! | ||
| GENEDX | 135,80 | +3,34 % | GeneDx Taps Dr. Linda Genen as Chief Medical Officer | ||
| BRIGHTSPRING HEALTH SERVICES | 40,670 | +3,59 % | S&P Dow Jones Indices: BrightSpring Health Services Set to Join S&P SmallCap 600 | NEW YORK, Oct. 14, 2025 /PRNewswire/ -- BrightSpring Health Services Inc. (NASD: BTSG) will replace Veritex Holdings Inc. (NASD: VBTX) in the S&P SmallCap 600 effective... ► Artikel lesen | |
| PACS GROUP | 40,880 | 0,00 % | Morning Market Movers: Mobile-health Network Solutions, PACS Group, Brera Holdings, Cerence See Big Swings | SANTA CLARA (dpa-AFX) - At 7:55 a.m. ET on Thursday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 34,720 | 0,00 % | PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance | SAN JOSE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| PROGYNY | 26,670 | +0,09 % | Progyny, Inc. Announces Third Quarter 2025 Results | Reports Revenue of $313.3 Million, Reflecting 9.3% GrowthRaises Full Year Guidance to Reflect Continued Strength in Member EngagementSelling Season Yields Over 80 New Clients, 900,000 New Lives, and... ► Artikel lesen | |
| ONCOLOGY INSTITUTE | 4,130 | +5,09 % | Oncology Institute, Inc. - 8-K, Current Report | ||
| GERRESHEIMER | 27,900 | 0,00 % | Gerresheimer Aktie: Einer der Rebound-Favoriten für 2026! | © Foto: Foto von Tima Miroshnichenko auf PexelsNach einem verheerenden Börsenjahr 2025 könnte die Gerresheimer-Aktie jetzt die große Überraschung werden.Der Pharmaverpackungs-Spezialist aus Düsseldorf... ► Artikel lesen | |
| BILLIONTOONE | 94,93 | -0,39 % | BillionToOne, Inc.: BillionToOne Reports Third Quarter 2025 Results | MENLO PARK, Calif., Dec. 09, 2025 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are... ► Artikel lesen | |
| RXSIGHT | 9,990 | -4,58 % | RxSight, Inc. Announces Chief Financial Officer Transition | ALISO VIEJO, Calif., Dec. 22, 2025 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery... ► Artikel lesen | |
| CERIBELL | 21,730 | 0,00 % | CBLL Wins FDA Breakthrough Status for AI-Based LVO Stroke Detection |
Das Unternehmen SHOULDER INNOVATIONS INC kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 12,000 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu SHOULDER INNOVATIONS INC finden Sie auf Wallstreet Online.